Tissue factor in infection and severe inflammation

被引:121
作者
Levi, M
van der Poll, T
ten Cate, H
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Expt Med Lab, NL-1105 AZ Amsterdam, Netherlands
[3] Acad Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands
关键词
coagulation; inflammation; infection; tissue factor; mononuclear cells; endothelium;
D O I
10.1055/s-2006-933338
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the pathogenesis of vascular disease, inflammation and coagulation play a pivotal role. Increasing evidence points to an extensive cross-talk between these two systems, whereby inflammation not only leads to activation of coagulation, but coagulation also considerably affects inflammatory activity. Tissue factor (TF) plays an important role at the crossroad of coagulation and inflammation, as the principal initiator of coagulation and an Important modulator of Inflammation. Proinflammatory cytokines can induce TF expression on mononuclear cells and endothelial cells and thereby commence pathways that lead to thrombin generation. Simultaneously, TF may bind to cellular receptors, which may affect the production and release of inflammatory mediators. There is increasing experimental evidence that TF inhibition may have beneficial effects In disease states in which the combination of coagulation and inflammation plays a prominent role.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 59 条
  • [21] Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
    Esmon, CT
    [J]. BLOOD, 2000, 95 (04) : 1113 - 1116
  • [22] Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis
    Gando, S
    Kameue, T
    Morimoto, Y
    Matsuda, N
    Hayakawa, M
    Kemmotsu, O
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (08) : 1729 - 1734
  • [23] Blood-borne tissue factor:: Another view of thrombosis
    Giesen, PLA
    Rauch, U
    Bohrmann, B
    Kling, D
    Roqué, M
    Fallon, JT
    Badimon, JJ
    Himber, J
    Riederer, MA
    Nemerson, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 2311 - 2315
  • [24] ACTIVATION AND INHIBITION OF HAGEMAN FACTOR-DEPENDENT PATHWAYS AND THE COMPLEMENT-SYSTEM IN UNCOMPLICATED BACTEREMIA OR BACTERIAL SHOCK
    KALTER, ES
    DAHA, MR
    TENCATE, JW
    VERHOEF, J
    BOUMA, BN
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (06) : 1019 - 1027
  • [25] DETERMINATION OF PLASMA TISSUE FACTOR ANTIGEN AND ITS CLINICAL-SIGNIFICANCE
    KOYAMA, T
    NISHIDA, K
    OHDAMA, S
    SAWADA, M
    MURAKAMI, N
    HIROSAWA, S
    KURIYAMA, R
    MATSUZAWA, K
    HASEGAWA, R
    AOKI, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) : 343 - 347
  • [26] The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia
    Levi, M
    VanderPoll, T
    TenCate, H
    VanDeventer, SJH
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (01) : 3 - 9
  • [27] Bidirectional relation between inflammation and coagulation
    Levi, M
    van der Poll, T
    Büller, HR
    [J]. CIRCULATION, 2004, 109 (22) : 2698 - 2704
  • [28] Current understanding of disseminated intravascular coagulation
    Levi, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (05) : 567 - 576
  • [29] Infection and inflammation and the coagulation system
    Levi, M
    Keller, TT
    van Gorp, E
    ten Cate, H
    [J]. CARDIOVASCULAR RESEARCH, 2003, 60 (01) : 26 - 39
  • [30] The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis
    Levi, M
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (08) : 1914 - 1915